First Time Loading...
O

Oncolys Biopharma Inc
TSE:4588

Watchlist Manager
Oncolys Biopharma Inc
TSE:4588
Watchlist
Price: 706 JPY -0.56% Market Closed
Updated: May 3, 2024

Oncolys Biopharma Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oncolys Biopharma Inc
Revenue Peer Comparison

Comparables:
2160
4587
4974
J
7774
S
4599

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
O
Oncolys Biopharma Inc
TSE:4588
Revenue
¥63m
CAGR 3-Years
-41%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Revenue
¥26B
CAGR 3-Years
39%
CAGR 5-Years
39%
CAGR 10-Years
64%
PeptiDream Inc
TSE:4587
Revenue
¥28.7B
CAGR 3-Years
35%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Revenue
¥47.7B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
8%
J
Japan Tissue Engineering Co Ltd
TSE:7774
Revenue
¥2.4B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
11%
S
StemRIM Inc
TSE:4599
Revenue
¥2.4B
CAGR 3-Years
4%
CAGR 5-Years
64%
CAGR 10-Years
N/A

See Also

What is Oncolys Biopharma Inc's Revenue?
Revenue
63m JPY

Based on the financial report for Dec 31, 2023, Oncolys Biopharma Inc's Revenue amounts to 63m JPY.

What is Oncolys Biopharma Inc's Revenue growth rate?
Revenue CAGR 5Y
-18%

Over the last year, the Revenue growth was -94%. The average annual Revenue growth rates for Oncolys Biopharma Inc have been -41% over the past three years , -18% over the past five years .